"One of the greatest challenges in cancer immunotherapy is finding the rare immune cells, called tumor-reactive T cells, whose job it is to recognize and eliminate tumor cells." - Johns Hopkins Kimmel Sidney Kimmel Comprehensive Cancer Center.
https://cancerletter.com/sponsored-article/20260605_6/
One of the greatest challenges in cancer immunotherapy is finding the rare immune cells, called tumor-reactive T cells, whose job it is to recognize and eliminate tumor cells. The immune cells collected from a tumor are specific for other targets the patient may have encountered in the past—viruses like flu, COVID, or other pathogens unrelated […]
